Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal vaccines in Canadian adolescents (CIRN Achieve01 study)
NCT03694405Phase 4Completed
- Sponsor
- Canadian Immunization Research Network
- Start
- Sep 2018
- Primary completion
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal A conjugate vaccine, Meningococcal polysaccharide vaccine group W-135 in invasive meningococcal disease (IMD), sponsored by Canadian Immunization Research Network. Started Sep 2018; status: completed.
02
Drugs
meningococcal A conjugate vaccineMeningococcal polysaccharide vaccine group W-135
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT03694405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694405.